Health
New medicine approved to treat schizophrenia
Cobenfy is the first drug to treat the disease that targets the brain's cholinergic receptors
Washington: The US Food and Drug Administration has approved a new drug for adults with schizophrenia.
The drug, commonly known as Cobenfy, is the first drug to treat the disease that targets the brain's cholinergic receptors, rather than the dopamine receptors that are the traditional focus of treatment.
“Schizophrenia is the leading cause of disability worldwide,” said Dr. Tiffany Farshion in the Institute's Department of Neuroscience.
He stated the drug represents the first new approach to treating schizophrenia. It offers a new alternative to the antipsychotic drugs that have previously been prescribed to people with schizophrenia.
It is pertinent to note that schizophrenia is a severe, chronic mental illness that often impairs a person's quality of life.
-
Pakistan 2 days ago
Pakistan to not progress without good politics: Maryam Nawaz
-
Pakistan 2 days ago
Zartaj Gul granted interim bail in vandalism case
-
Pakistan 2 days ago
Suicide bomber woman confesses being brainwashed, beguiled
-
Business 2 days ago
FBR to abolish category of non-filers
-
Business 2 days ago
Gold price hikes by Rs2,500 per tola in Pakistan
-
Business 2 days ago
Pakistan's economy improving, inflation declining: ADB
-
Entertainment 2 days ago
Amar Khan calls nation ‘ignorant’ for commenting on others
-
World 2 days ago
Hezbollah missile attack on Mossad headquarters near Tel Aviv